Erlotinib (Multichem)

Ország: Új-Zéland

Nyelv: angol

Forrás: Medsafe (Medicines Safety Authority)

Aktív összetevők:

Erlotinib hydrochloride 109.267mg equivalent to erlotinib 100mg

Beszerezhető a:

Multichem NZ Limited

Adagolás:

100 mg

Gyógyszerészeti forma:

Film coated tablet

Összetétel:

Active: Erlotinib hydrochloride 109.267mg equivalent to erlotinib 100mg Excipient: Opadry White 20B58900 Lactose monohydrate Magnesium stearate Microcrystalline cellulose Sodium laurilsulfate Sodium starch glycolate

Recept típusa:

Prescription

Terápiás javallatok:

· Erlotinib is indicated for the first-line and maintenance treatment of patients with advanced (Stage IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC) with activating EGFR mutations. · Erlotinib is also indicated for the treatment of patients with locally advanced or metastatic non small cell lung cancer (NSCLC) who have previously received chemotherapy.

Termék összefoglaló:

Package - Contents - Shelf Life: Blister pack, PVC/Al foil strips in cardboard carton - 30 tablets - 36 months from date of manufacture stored at or below 25°C

Engedély dátuma:

2020-04-15